Books by Oliver Gassmann

Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade.

Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade.

Presenting a broad literature review of scholarly work in the area of Business Model Innovation, this new book analyses 50 management theories in the context of BMI to yield valuable new insights.

What are the secrets of competitive R&D on a global scale? Based on research with hundreds of R&D executives from more than 80 companies and 1000 R&D laboratories, this work presents fresh concepts and trends in global R&D management. It also includes case studies from 22 best-practice companies that show how to put these concepts into practice.